Aleen C. Hosdaghian Email & Phone Number

Spearheaded the largest immunology launch planned in Dermatology for 2023, bimekizumab, with P&L responsibility. - Developed a comprehensive Strategic Roadmap with Launch Excellence Team - Led Brand Planning and ensured strategic alignment with launch vision and initiative transparency with cross-functional team members spanning HCP, Omni, Patient, P2P, Analytics, Comm Ops, Sales, Eco, TLL, Patient Services, Insights, Sales, Payer, and Leadership. - Optimized resources for a seamless blockbuster launch - Served as the U.S. Leader in the Global Core Working Group for worldwide launch strategy development and 3YR brand Arc. - Established leadership and advocacy towards Digital Business Transformation at UCB.

As Senior Director of Marketing for Specialty Dermatology at SUN Pharma, had full P&L responsibility for both laBCC and actinic keratoses indications ODOMZO and LEVULAN KERASTICK + BLU-U in Dermatology. - Led a dynamic team of 3 and the team achieved notable growth while also significantly boosting market share through innovative marketing strategies that aligned with external stakeholders and market dynamics. - Additionally, played a pivotal role in driving new indication development and commercialization efforts for nextgen device, performed due diligence for potential acquisitions. - Led a successful corporate rebranding initiative following SUN Pharma's acquisition of DUSA

Detroit, Michigan, United States

Developed and implemented a new market strategy to drive increased patient use for a diverse portfolio of over 75 products marketed to dispensing dermatologists, holding full P&L responsibility. - Conducted comprehensive training programs for local physicians, aestheticians, and office managers nationwide in the United States. - Authored policies and Statements of Work (SOW) to ensure compliance with OPDP regulations, involving medical, legal, and regulatory reviews. - Established a highly successful Brand Ambassador program in collaboration with Key Opinion Leaders, resulting in an increase in overall market share within the anti-aging product category. - Fostered cross-functional collaboration with marketing teams at Industrial Farmaceutica Cantabria, S.A. headquarters in Spain and globally to develop and align strategies across markets. - Led a team of four marketers in the U.S., driving cohesive marketing efforts and achieving strategic objectives.

Successfully developed and executed marketing plans for the launch of four brands and one line extension, along with the implementation of a corporate branding initiative. - Led and managed the marketing department team of 3, evaluating potential product acquisitions from industry leaders such as Pfizer, Merck, J&J, NovaDel, and others. - Achieved significant results, including increase in annual revenue for LOCOID Lotion and a notable growth in market share for Pyratine-6. - Initiated collaborative studies with Brooke Army Medical Center to develop and launch MINOCIN I.V. - Collaborated with FIDEC to provide essential antibiotic care to children in Buenos Aires. - Responsible for overseeing a diverse portfolio of products, including LOCOID Lotion (addressing inflammation caused by allergic reactions, eczema, or psoriasis), TIROSINT (treating hypothyroidism), NITROMIST (pituitary TSH suppression), and MINOCIN I.V. (treating infections due to susceptible bacteria, including Acinetobacter and MRSA).

Helped launch Eau Thermale Avène, the leading dermatological skincare brand in France, into the US dermatology and mass markets. - Developed comprehensive segmentation and consumer strategic plans for both mass and dispensing channels, encompassing a portfolio of over 115 products. -Executed targeted marketing programs to engage various stakeholders, including physicians, pharmacists, NP/PA's, aestheticians, patients, educators, retailers, and pharmacy directors. - Program initiatives included advocacy development, disease awareness programs, conventions, advisory boards, Key Opinion Leader (KOL) development, and quarterly campaigns. - Achieved impressive year-over-year sales growth - Collaborated closely with L'Oréal Alliance to help conceptualize and establish Skin Centers within major retail chains such as Rite-Aid, CVS, and Walgreens across the United States. - Fostered strong relationships with cross-functional teams and global marketing counterparts in Toulouse, ensuring alignment on 1- and 3-year Brand Plans to drive success in the US market.

Business Development Manager for the East Coast for the pre-drug discovery platform PROhit, focusing on protein folding. - Managed key accounts, including Genzyme, Sanofi-Synthelabo, Genentech, and Regeneron. - Achieved annual sales exceeding $4 million. - Collaborated with the parent company in Salzburg to formulate annual sales and marketing plans. - Played a pivotal role in developing target lists and conducting comprehensive field and classroom training for internal and external stakeholders. - Established a robust value prop and message platform for the brand and created impactful U.S. market pull-through materials to drive success.

Certificate, Organizational Leadership

Master Of Science, Computational Biology

Graduated with a dual degree from both Rutgers and NJIT with an M.S. in Computational Biology

Bachelors, Biology

Activities and Societies: Alpha Phi, Les ChanteusesBachelor of Science in Biology

High School Diploma